![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Laganà Bruno Vinciguerra Marta D'Amelio Raffaele
Publisher: Adis International
ISSN: 1173-2563
Source: Clinical Drug Investigation, Vol.29, Iss.3, 2009-02, pp. : 185-202
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Abatacept attains responses in rheumatoid arthritis
Inpharma, Vol. 1, Iss. 1463, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Abatacept takes aim at rheumatoid arthritis
Inpharma, Vol. 1, Iss. 1501, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Abatacept a strong option for rheumatoid arthritis therapy
Inpharma, Vol. 1, Iss. 1663, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Zenibayashi M Saigo K Chayahara N Sakamoto Y Inujima K Imamura Y Takada M Kawano S Tatsumi E Kumagai S
The Journal of International Medical Research, Vol. 33, Iss. 5, 2005-09 ,pp. :